124
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Long-Term Trends in Hospitalization and Outcomes in Adult Patients with Exacerbation of Chronic Obstructive Pulmonary Disease in Beijing, China, from 2008 to 2017

ORCID Icon, , , , &
Pages 1155-1164 | Published online: 21 May 2020

References

  • GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788.30496103
  • ZhouM, WangH, ZhuJ, et al. Cause-specific mortality for 240 causes in China during 1990–2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387:251–272. doi:10.1016/S0140-6736(15)00551-626510778
  • ZhongN, WangC, YaoW, et al. Prevalence of Chronic Obstructive Pulmonary Disease in China. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC17575095
  • WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet (London, England). 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • KhakbanA, SinDD, FitzGeraldJM, et al. Ten-year trends in direct costs of COPD: a population-based study. Chest. 2015;148(3):640–646. doi:10.1378/chest.15-072126043120
  • ZhuB, WangY, MingJ, et al. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi:10.2147/COPD.S16155529731623
  • COPD Group of Chinese Society of Respiratory Disease. Guideline for diagnosis and treatment of chronic obstructive pulmonary disease (revised edition in 2013). Chin J Front Med Sci. 2013;6:67–70.
  • Chinese Expert Group on the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Chinese expert consensus on the diagnosis and treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) (revised edition in 2014). Int J Respir. 2014;34:1–11.
  • HuangJ, PanX, GuoX, et al. Health impact of China’s air pollution prevention and control action plan: an analysis of national air quality monitoring and mortality data. Lancet Planet Health. 2018;2:e313–e23. doi:10.1016/S2542-5196(18)30141-430074894
  • LiangL, CaiY, BarrattB, et al. Associations between daily air quality and hospitalisations for acute exacerbation of chronic obstructive pulmonary disease in Beijing, 2013–17: an ecological analysis. Lancet Planet Health. 2019;3:e270–e9. doi:10.1016/S2542-5196(19)30085-331229002
  • LiYQ, ShiJH, CaoY, et al. [One year after the implementation of 2015 tobacco control regulation on persons aged 15 years and over tobacco use in Beijing]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018;39:1188–1192. Chinese. doi:10.3760/cma.j.issn.0254-6450.2018.09.00930293308
  • Beijing Municipal Bureau of Statistics. http://www.bjstats.gov.cn. Accessed 1018, 2018.
  • National Bureau of Statistics of China. 2010 Population census. Available from: http://www.stats.gov.cn/english/Statisticaldata/CensusData/. Accessed 1028, 2018.
  • National Bureau of Statistics of China. Available from: http://data.stats.gov.cn/easyquery.htm?cn=C01. Accessed 119, 2018.
  • HJK, FayMP, FeuerEJ, MidthuneDN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z10649300
  • Chinese Center for Disease Control and Prevention. 2015 Chinese Adult Tobacco Survey Country Reports; 2015.
  • MengQ, XuL, ZhangY, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet. 2012;379:805–814. doi:10.1016/S0140-6736(12)60278-522386034
  • LiL, FuH. China’s health care system reform: progress and prospects. Int J Health Plann Manage. 2017;32:240–253. doi:10.1002/hpm.242428612498
  • PanJ, LeiX, LiuGG. Health insurance and health status: exploring the causal effect from a policy intervention. Health Econ. 2016;25:1389–1402. doi:10.1002/hec.322526350053
  • de Miguel-diezJ, Jimenez-GarciaR, Hernandez-BarreraV, et al. Trends in hospital admissions for acute exacerbation of COPD in Spain from 2006 to 2010. Respir Med. 2013;107:717–723. doi:10.1016/j.rmed.2013.01.00723421969
  • JinjuvadiaC, JinjuvadiaR, MandapakalaC, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. Copd. 2017;14:72–79. doi:10.1080/15412555.2016.119966927419254
  • KurmiOP, DavisKJ, Hubert LamKB, et al. Patterns and management of chronic obstructive pulmonary disease in urban and rural China: a community-based survey of 25 000 adults across 10 regions. BMJ Open Respir Res. 2018;5:e000267. doi:10.1136/bmjresp-2017-000267
  • LiuY, ZhongL, YuanS, et al. Why patients prefer high-level healthcare facilities: a qualitative study using focus groups in rural and urban China. BMJ Glob Health. 2018;3:e000854. doi:10.1136/bmjgh-2018-000854
  • FuhrrmanC, RocheN, Vergne`greA, et al. Hospital admissions related to acute exacerbations of chronic obstructive pulmonary disease in France, 1998–2007. Respir Med. 2011;105:595. doi:10.1016/j.rmed.2010.11.01421130636
  • de Miguel-diezJ, Jimenez-GarciaR, Hernandez-BarreraV, et al. Readmissions following an initial hospitalization by COPD exacerbation in Spain from 2006 to 2012. Respirology. 2016;21:489–496. doi:10.1111/resp.1270526648085
  • StefanMS, ShiehM-S, PekowPS, et al. Trends in mechanical ventilation among patients hospitalized with acute exacerbations of COPD in the United States, 2001 to 2011. Chest. 2015;147:959–968. doi:10.1378/chest.14-121625375230
  • LindenauerPK, StefanMS, ShiehM-S, et al. Outcomes associated with invasive and noninvasive ventilation among patients hospitalized with exacerbations of chronic obstructive pulmonary disease. JAMA Intern Med. 2014;174:1982–1993. doi:10.1001/jamainternmed.2014.543025347545
  • OsadnikCR, TeeVS, Carson-ChahhoudKV, et al. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:CD004104. doi:10.1002/14651858.CD003881.pub428702957
  • ChenW, FitzGeraldJM, SinDD, et al. Excess economic burden of comorbidities in COPD: a 15-year population-based study. Eur Respir J. 2017;50:pii: 1700393. doi:10.1183/13993003.00393-2017
  • DenizS, SengulA, AydemirY, et al. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:3023–3030. doi:10.2147/COPD.S12063727980399
  • LiuH, WangN, ChenW, et al. Hospitalization trends in adult patients with COPD and other respiratory diseases in northeast China from 2005 to 2015. Biomed Res Int. 2018;2018:1060497.29581961